How many drugs treat Cerebral embolism?

Drug Landscape tracks 3 marketed treatments for Cerebral embolism (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/cerebral-embolism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cerebral embolism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cerebral embolism (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Cerebral embolism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Plavix	clopidogrel	Generic (originally Sanofi/BMS)	Thienopyridine antiplatelet agent	Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter	1997-11-17
Coumadin	warfarin	Generic (originally Wisconsin Alumni Research Foundation)	Vitamin K antagonist (anticoagulant)	Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7	1954-01-01
Dicuman	dicoumarol	AbbVie	dicoumarol	NAD(P)H dehydrogenase [quinone] 1	1944-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 1 drug in Cerebral embolism
Generic (originally Sanofi/BMS) · 1 drug in Cerebral embolism
Generic (originally Wisconsin Alumni Research Foundation) · 1 drug in Cerebral embolism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Cerebral embolism:

Cite this brief

Drug Landscape (2026). Cerebral embolism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/cerebral-embolism. Accessed 2026-06-10.

Cerebral embolism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing